Suppr超能文献

丝状线虫表型筛选级联反应,用于鉴定具有抗寄生虫活性的化合物,以优化药物发现。

Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization.

机构信息

Bristol Myers Squibb, San Diego, CA, USA.

New England Biolabs, Ipswich, MA, USA.

出版信息

Int J Parasitol Drugs Drug Resist. 2022 Aug;19:89-97. doi: 10.1016/j.ijpddr.2022.06.002. Epub 2022 Jun 23.

Abstract

Filarial diseases, including lymphatic filariasis and onchocerciasis, are considered among the most devastating of all tropical diseases, affecting over 86 million people worldwide. To control and more rapidly eliminate onchocerciasis requires treatments that target the adult stage of the parasite. Drug discovery efforts are challenged by the lack of preclinical animal models using the human-pathogenic filariae, requiring the use of surrogate parasites for Onchocerca volvulus for both ex vivo and in vivo evaluation. Herein, we describe a platform utilizing phenotypic ex vivo assays consisting of the free-living nematode Caenorhabditis elegans, microfilariae and adult filariae of the bovine filariae Onchocerca lienalis and Onchocerca gutturosa, respectively, as well as microfilariae and adult filariae of the feline filariae Brugia pahangi, the rodent filariae Litomosoides sigmodontis and the human-pathogenic filariae Brugia malayi to assess activity across various surrogate parasites. Utilization of those surrogate nematodes for phenotypic ex vivo assays in order to assess activity across various parasites led to the successful establishment of a screening cascade and identification of multiple compounds with potential macrofilaricidal activity and desirable physicochemical, MW = 200-400 and low lipophilicity, logP <4, and pharmacokinetic properties, rat and human liver S9 stability of ≥70% remaining at 60 min, and AUC exposures above 3 μM h. This platform demonstrated the successful establishment of a screening cascade which resulted in the discovery of potential novel macrofilaricidal compounds for futher drug discovery lead optimization efforts. This screening cascade identified two distinct chemical series wherein one compound produced a significant 68% reduction of adult Litomosoides sigmodontis in the mouse model. Successful demonstration of efficacy prompted lead optimization medicinal chemistry efforts for this novel series.

摘要

丝虫病,包括淋巴丝虫病和盘尾丝虫病,被认为是所有热带病中最具破坏性的疾病之一,影响全球超过 8600 万人。为了控制和更迅速地消除盘尾丝虫病,需要针对寄生虫的成虫阶段进行治疗。由于缺乏使用人致病性丝虫的临床前动物模型,药物发现工作受到了挑战,这需要使用盘尾丝虫的替代寄生虫,用于体外和体内评估。在此,我们描述了一个利用表型体外测定的平台,该平台由自由生活的线虫秀丽隐杆线虫、微丝蚴和牛丝虫奥氏丝虫和奥氏副丝虫的成虫组成,以及猫丝虫班氏吴策线虫、鼠丝虫链尾丝虫和人致病性丝虫班氏丝虫的微丝蚴和成虫。利用这些替代线虫进行表型体外测定,以评估各种寄生虫的活性,成功建立了一个筛选级联,并鉴定出多种具有潜在杀成虫活性的化合物,这些化合物具有理想的理化性质,MW=200-400,低亲脂性,logP<4,以及药代动力学特性,大鼠和人肝 S9 稳定性在 60 分钟时至少保持 70%,AUC 暴露量超过 3μM·h。该平台成功地建立了一个筛选级联,发现了具有进一步药物发现先导优化潜力的潜在新型杀成虫化合物。该筛选级联确定了两个不同的化学系列,其中一种化合物在小鼠模型中使奥氏副丝虫成虫的数量显著减少了 68%。成功证明了疗效,促使对这一新系列进行了先导优化的药物化学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a666/9278491/5ea38708036e/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验